您好,欢迎访问中国水产科学研究院 机构知识库!

Development of a vaccine against Streptococcus agalactiae in fish based on truncated cell wall surface anchor proteins

文献类型: 外文期刊

作者: Liu, H. 1 ; Zhang, S. 3 ; Shen, Z. 3 ; Ren, G. 2 ; Liu, L. 3 ; Ma, Y. 3 ; Zhang, Y. 1 ; Wang, W. 4 ;

作者机构: 1.Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev, Key Lab Aquat Sci Chongqing, Chongqing 400715, Peoples R China

2.Binzhou Marine Environm Monitoring Stn, Binzhou 256600, Shandong, Peoples R China

3.Shandong Lvdu Biotechnol Co Ltd, Shandong Binzhou Anim Sci & Vet Med Acad, Binzhou 256600, Shandong, Peoples R China

4.Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao 266071, Peoples R China

期刊名称:VETERINARY RECORD ( 影响因子:2.695; 五年影响因子:2.797 )

ISSN: 0042-4900

年卷期: 2016 年 179 卷 14 期

页码:

收录情况: SCI

摘要: Streptococcus agalactiae is an important fish pathogen and a leading cause of major economic losses to the aquaculture industry worldwide. In the present study, the two truncated recombinant proteins of cell wall surface anchor family of S agalactiae, CWSAP465 and CWSAP1035, were expressed in Escherichia coli, and their immunogenicity and efficacy against the bacterium were evaluated in tilapia and turbot. The results showed that the prokaryotic expression of the two constructs, p32a-CWSAP465 and p32a-CWSAP1035, gave rise to a high yield of soluble proteins with good immunogenicity. The immunisation-challenge study revealed that tilapia and turbot immunised with recombinant truncated proteins produced high levels of antibodies with a peak at four weeks after immunisation and were protected from a challenge by a virulent S agalactiae at a dose of 1x10(9) colony forming units/ml. The recombinant truncated proteins had higher efficacy than the whole-cell inactivated vaccine. Therefore, the study demonstrated that CWSAP465 and CWSAP1035 are two viable vaccine candidates against S agalactiae in fish.

  • 相关文献
作者其他论文 更多>>